Abstract

Report of the Second Satellite Symposium on Ultrasound in Schistosomiasis

Vol. 96, Suppl.: 151-156, 2001

Joachim Richter/⁺ + Corresponding author. E-mail: joachim.richter1@uni-duesseldorf.de Received 14 May 2001 Accepted 25 July 2001 , Ana Lúcia Coutinho Domingues*, Cristina H Barata**, Aluizio R Prata**, José Roberto Lambertucci***

Heinrich-Heine-UniversitaetDuesseldorf, Tropenmedizinische Ambulanz, Geb.11.93, Moorentr. 5, D-40225 Duesseldorf, FR Germany *Universidade Federal de Pernambuco, Recife, PE, Brasil **Faculdade de Medicina do Triângulo Mineiro, Uberaba, MG, Brasil ***Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil

A group of experts on schistosomiasis and ultrasonography discussed the experiences and results obtained with the Niamey-Belo Horizonte Protocol on Ultrasonography in Schistosomiasis. A series of recomendations about qualitative and quantitative data obtained by ultrasound in studies performed in Africa and Brazil are presented. Imunological, genetic and epidemiological studies must rely on ultrasound for the identification of patients with periportal thickening/fibrosis.

Key words: schistosomiasis - schistosomiasis mansoni - ultrasound - periportal fibrosis

Ultrasonography (US) is the tool of first choice for assessing liver and spleen changes induced by Schistosoma spp. in endemic regions; it is the most economic imaging technique which permits the assessment of abdominal organs. Another advantage is that US can be performed using portable devices which allow its application in remote areas. In areas without electricity network US devices can be powered by portable generators.

The specificity of the characteristic US features of periportal fibrosis has been proven in several endemic areas like Brazil (Cerri et al. 1984), Sudan (Homeida et al. 1988) and Egypt (Abdel Wahab et al. 1989). Since in these studies different methodologies have been applied, data obtained were not directly comparable on an international scale. This prompted the World Health Organization to sponsor and assemble an International Expert Meeting in Cairo in 1991. A standardized protocol was developed and published (Cairo Working Group 1992). This protocol was revised by an expert group in Niamey, Niger in 1996, and during the previous First Satellite Symposium on Ultrasonography in Schistosomiasis in Belo Horizonte 1997 (Niamey Working Group 2000). The aim of the present Satellite Symposium was to discuss the practical experiences and results obtained with the Niamey-Belo Horizonte US protocol.

The protocol has been applied in Uganda, Senegal, Brazil and Cambodia (to assess Schistosoma mekongi-associated morbidity (Christoph Hatz, pers. commun., 1999; this latter study is not reported here). Approximative figures are given because data analysis has not yet been completed (Table).

Table

The following criteria of the usefulness of the various parameters of the Niamey-Belo Horizonte protocol were chosen: simplicity, reproducibility, time spent, relation to clinical status, power to differentiate between patients and control subjects (Minas Gerais study)

Measurement of segmental portal branch wall thickness

After some training measurements are generally easy to perform by experienced ultrasonographists but this is not the case with less experienced examiners (Uganda, Senegal studies).

Reproducibility has been found unacceptably low in sub-samples of patients in Uganda and Senegal. Interobserver variance appears to decrease after training. However, even when performed by experienced ultrasonographists, reproducibility of measurements was unsatisfactory (Senegal).

Although the measurements of the portal branch walls take relatively long time this would be acceptable if the other criteria above were fulfilled.

Measurements were not found to reflect adequately the clinical status (hematemesis due to variceal bleeding, for example) in advanced cases in Senegal.

Image patterns (IP)

IP (Figs 1, 2, 3, 4, 5, 6, 7, 8) are easily understood by experienced and less experienced examiners.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Interobserver variance was low when training of the different examiners had taken place before (Uganda, Senegal). It is sometimes difficult to discern a pattern D from slight thickening of the wall of the main portal vein. Therefore a measurement should be introduced which allows objectivation of the finding. The best way of assessing "central periportal thickening" appears to be to measure the wall at portal bifurcation in front of the portal trunk in a oblique liver scan. In the Minas Gerais study normal values of this measurement have been established (up to 5 mm in individuals with a weight up to 40 kg, and 6 mm in subjects weighing more than 40 kg). Data will be reanalyzed in function of body height.

IP assignment does not take much time. Contrary to measurements, when the examiner is looking for IP, he or her concentrates on parenchyma changes.

IP A, Dc-F reflected adequately the clinical status of all patients examined. IP B was found to be non-specific as it may be observed in children, after starvation, and in viral infections (e.g. a measle case in Germany). IP Dc (mild periportal thickening around the portal stem and the peripheral branches) seems to have a worse clinical prognosis than D alone (central periportal thickening alone without peripheral thickening (Gerspacher-Lara et al. 1997). Most of the complicated cases have patterns E, Ec or F (advanced periportal thickening).

Liver measurements

Left liver lobe measurement is easily and rapidly performed. Right liver lobe measurement takes longer because the right liver lobe usually exceeds the dimensions of the US probe and measurement has to be done by adding partial diameters.

For the same reason left liver lobe measurement is less subjected to intra-and inter-observer variance than that of the right liver lobe.

Measurement of the right liver lobe takes almost twice the time as compared to left lobe measurement.

Relation of liver measurements to clinical status has not yet been assessed systematically in the above study.

Portal hypertension assessment

Whereas the measurement of portal vein diameter at the liver hilus and detection of ascites do not require exceptional skills, the capacity in detecting collaterals largely depends on the experience of the examiner and the preparation of the patient.

Reproducibility of portal vein measurements has been found excellent in Senegal and Uganda. Once the ultrasonographist is well trained in taking the measurement neither different experience of the examiner nor different quality of US devices interfered with measurement results. In hospitalized patients Doppler examination can be performed. However, reproducibility of Doppler measurements has never been investigated in schistosomiasis patients

Portal vein measurement is rapid. In hospitalized patients in Pernambuco, the measurement of the splenic vein behind the pancreas correlated better with portal and intravariceal pressure than portal vein diameter. Splenic vein measurement behind the pancreas requires a good preparation of the patient. The high respiratory variation of this vessel (50%) in healthy subjects may be a confounding factor. It was therefore felt that this measurement including the assessment of respiration variation is recommended in hospitalized patients but was less useful in the field. The Niamey-Belo Horizonte Portal Hypertension score was found to reflect more the clinical status of four Senegalese patients with complicated periportal fibrosis than other scores tested in the past (Abdel-Wahab et al. 1993, Richter et al. 1998).

Additional investigations

Gall-bladder wall assessment should be integrated into the core protocol. Measurement is rapidly performed and adjustment to other biometric data is simple (up to 3 mm in individuals with a weight <= 30 kg, up to 4 mm in individuals > 30 kg). Characteristic changes (hyperechoic protrusions from the gall-bladder wall into the parenchyma) should be reported. Gall-bladder changes may precede periportal changes in a part of infected individuals and may therefore have an independent prognostic significance (Pinto da Silva et al. 1994).

In non-malarious areas spleen length should be always assessed. Spleen measurements may be also useful in areas of low levels of malaria endemicity. Data obtained in a holoendemic area (Uganda) are yet to be analyzed.

The gold standard for the assessment of the specificity of US in vivo is liver biopsy. However, it must be stressed that the way of taking liver biopsies and the volume of the biopsy sample may interfere with biopsy results. A deep wedge liver biopsy of the left liver lobe obtained during surgery or laparoscopy has the highest sensitivity. For ethical reasons this invasive procedure can not be performed in patients with early lesions. Blind liver punction does usually not yield enough material and fibrotic material is frequently not easily aspirated. Classification criteria have to be uniform discerning between an egg granuloma and periportal fibrosis. Classifications must be standardized (Coutinho-Domingues 1998). Inter-observer variance in judging the sample must also be assessed.

"Hepatosplenic schistosomiasis" is a clinical definition which is not synonymous with periportal thickening as assessed by US. This is crucial when judging any kind of studies (genetic, immunological, epidemiologic), classifiying patients by one of these or both methods (Lambertucci et al. 2000).

1- Hepatosplenic schistosomiasis is also not synonymous with hepato-splenomegaly. Frequently the liver is not enlarged or even shrunken in patients with hepatosplenic schistosomiasis. The clinical definition of hepatosplenic schistosomiasis adopted by Aluizio Prata is the presence of a firm liver (left liver lobe) and a firm spleen palpable without breathing in a subject with parasitologically proven schistosomiasis. This definition is subject to high inter-observer-variance as it has been observed in Brazil, Uganda and Senegal (Lambertucci et al. 1996).

2 - Periportal fibrosis may occur without splenomegaly. Hyper-reactive splenomegaly may not be accompanied by ultrasonographically detectable periportal fibrosis. The relation between the different case definitions are illustrated in Fig. 9. The relation between the two case definitions (ideally maximal overlap percentage) has to be assessed in each endemic region and for each examination team.

3 - If US is applied to assess the value of clinical examination (to allow assessment of a high number of individuals in epidemiological surveys, when resources are limited) other parameters have to be included into the examination protocol. In the first phase, training of clinical examiners should be done with simultaneous ultrasound examination ("clinical hepatomegaly" was not associated to organ enlargement in a Senegalese sub-sample). Inter-observer variance should be reduced by intensive group training and ultrasound control in order to eliminate equivocal results.

4 - To allow direct comparison between clinical examination and US results, splenic measurements should include also the extension of the spleen below the costal margin in patients who do breathe quietly (not in deep inspiration). In huge splenomegaly palpation using the Hackett classification may be more adequate than ultrasonographic measurement, and could be reported on the US sheet.

Improvement of US in detecting early liver pathology:

1 - Comparative Necropsy-US studies in subjects infected with schistosomiasis but who died of other causes may be helpful in the identification of characteristic early US features. Here it is particularly important to use an unequivocal pathological definition of periportal fibrosis and to define and measure macroscopic lesions.

2 - Animal studies.

Actual US technology (portable devices) does not allow a clear-cut definition of early pathology.

High-tech US devices (e.g. with harmonic tissue imaging facility, examination of peripheral liver parenchyma with high frequency transducers, Doppler-US, contrast-Doppler-US)

Computed tomography (Cesmeli et al. 1997)

Helicoidal computed contrast-tomography

Magnetic resonance imaging (proved useful in neuroschistosomiasis)

Chronic hepatitis and alcoholic diseases are the major confounders when assessing US results in patients with schistosomiasis. Mixed hepatitis C and schistosomiasis is particularly frequent in Egypt, but periportal fibrosis and post-necrotic and/or alcoholic liver cirrhosis occur frequently also in some areas of Brazil. In epidemiological studies on hepatic morbidity alcoholism must be ruled out by careful medical history. Hepatitis B and C must be ruled out by the determination of at least HBsAg, and anti-HCV antibody .

Reports on abdominal ultrasound studies in patients with acute schistosomiasis are still scarce and limited data are available on changes of liver texture in this stage of the disease (Lambertucci et al. 1994). More recently, 26 patients with acute S. mansoni infection were submitted to clinical and ultraso-nographic examination by Barata et al. (1999). For comparison of ultrasound features, each patient was matched by age, gender, weight and height to a non-infected individual. In most patients (21/26) non-specific hepatosplenomegaly was observed without liver texture abnormalities which was frequently accompanied by intraabdominal lymph node swelling, especially around the portal hilus. Periportal thickening was observed in 5/26 patients. Three of these patients underwent percutaneous liver biopsy, which showed dense inflammatory infiltration of neutrophils, macrophages and eosinophils in the portal tracts associated with discrete fibrous tissue formation. Periportal thickening regressed six months after chemotherapy. Twenty four months post-therapy liver and spleen volumes had regressed to normal, whereas lymph nodes, although reduced in size were still easily recognized.

Intraabdominal lymph nodes may be seen also in healthy individuals, and lymphadenopathy can be observed in a variety of diseases other than schistosomiasis. The predictive value of particular hilar lymph node morphology changes observed in acute schistosomiasis but not in other disease (acute hepatitis, acute HIV-infection, acute EBV-infection etc.) is underway in Minas Gerais.

The preliminary data obtained with the Niamey-Belo Horizonte protocol since 1997 do not yet permit to formulate definite recommendations. The protocol needs to be tested further in different endemic areas and by different research groups.

Periportal branch wall measurements appear not to be reliable indicators of periportal fibrosis when analyzed alone, but should still be performed to evaluate this parameter.

It is emphasized that measurements in general must not be abandoned. Measurements increase the objectivity of the results if these fulfill the following criteria: (1) measurements must be reproducible among different examiners; (2) reflect the clinical status; (3) must be adjusted to individual biometric data (body height and/or weight). Best reproducibility is obtained for measurements between 5 mm and 5 cm, and structures which are not to close to the transducer (because convex transducers distort the image).

Gallbladder assessment should be included into the core protocol.

Adequate training is crucial not only of the ultrasonographist but also of examiners foreseen for clinical assessment in epidemiological studies. Quality assessment and training of palpation should rely also on simultaneous ultrasonography.

Scientific studies (immunological, genetic and epidemiological) must rely on US criteria for periportal fibrosis. The clinical definition of hepato-splenic schistosomiasis is not sufficient to differentiate patients with periportal fibrosis from intestinal schistosomiasis.

To the Organizing Committee of the VII International Symposium on Schistosomiasis, and in particular Dr Miriam Tendler for giving the opportunity and infrastructure for this Satellite Symposium. Hospitality, logistic and travel costs of Dr Richter were covered by Fiocruz, Rio de Janeiro, and Danish Bilharziasis Laboratory, Denmark. Dr Prata and Dr Lambertucci wish to thank CNPq, WHO and the National Health Foundation for sponsoring the work that has been developed in Brazil.

Fig. 1 | Fig. 2 | Fig. 3 | Fig. 4 | Fig. 5 | Fig. 6 | Fig. 7 | Fig. 8 | Fig. 9 | Table

Publication Dates

History